SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally has sparked breakout talk, with traders pointing to rising momentum, chart patterns, and the tokens limited supply; others remain skeptical, calling it a volatile bounce and questioning whether gains can hold.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports shares are drawing attention after RAP-219s Phase 2 bipolar-mania trial met its primary and secondary endpoints, prompting bullish reactions and analyst upgrades. Traders are debating whether the efficacy signal is strong enough to justify the surge, citing the modest placebo-adjusted improvement, higher discontinuation rate, and the stocks sharp retreat after its initial jump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Blue Moon Announces Further Results from Assays at Springer, Including a New Intercept of 0.3 m of 7.84% WO

Blue Moon Announces Further Results from Assays at Springer, Including a New Intercept of 0.3 m of 7.84% WO Blue Moon Announces Further Results from Assays at Springer, Including a New Intercept of 0.3 m of 7.84% WOPR NewswireTORONTO, Oct. 6, 2026TORONTO, Oct. 6, 2026 /PRNewswire/ -- Blue Moon...

Blue Moon Acquires the Turner Copper-Gold VMS Deposit to Further Advance its Western U.S. Critical Mineral Hub and Spoke Model

Blue Moon Acquires the Turner Copper-Gold VMS Deposit to Further Advance its Western U.S. Critical Mineral Hub and Spoke Model Blue Moon Acquires the Turner Copper-Gold VMS Deposit to Further Advance its Western U.S. Critical Mineral Hub and Spoke ModelPR NewswireTORONTO, Sept. 23, 2026 TORONTO...

Blue Moon Announces Initial Results from Assay Campaign of Historical Drilling at Springer, Including 7.00 m of 1.28% WO, Receives BLM Approval to Drill on Public Land and Advances Exploration Initiatives

Blue Moon Announces Initial Results from Assay Campaign of Historical Drilling at Springer, Including 7.00 m of 1.28% WO, Receives BLM Approval to Drill on Public Land and Advances Exploration Initiatives Blue Moon Announces Initial Results from Assay Campaign of Historical Drilling at Springer...

Five Stories Putting Traders on Notice: Insider Buying, FDA Catalysts, Psychedelic Breakthroughs and a U.S. Tungsten Rush

The market is once again rewarding investors willing to look beyond the headline indexes; NeOnc Technologies Holdings (NASDAQ:NTHI), Armata Pharmaceuticals (NYSEAMERICAN:ARMP), Definium Therapeutics (NASDAQ:DFTX), Basel Medical Group (NASDAQ:BMGL), Blue Moon Metals (NASDAQ:BMM) and The Elmet Group (NASDAQ:ELMT).

$450M U.S. Government Deal Supercharges Blue Moon and Elmet Group Tungsten Mine Plant

Blue Moon Metals (NASDAQ:BMM), The Elmet Group (NASDAQ:ELMT) and EQ Resources signed a binding letter agreement for transactions representing approximately $150 million of investment, with another $25 million available for standby requirements, aimed at restarting and expanding the Springer Tungsten Complex in Nevada and establishing a domestic U.S. tungsten supply chain.

ELMT Stock Soars Premarket: Elmet Lands $450M US Investment, $2B Defense Contract

Equity

A push to rebuild domestic tungsten supplies is putting ELMT and BMM in focus, with Elmet securing $450 million in government investment and a DLA contract worth up to $2 billion.

Blue Moon, The Elmet Group, and EQ Resources Announce a US$150-$175 Million Investment into the Springer Tungsten Complex, Nevada, to Strengthen the U.S. Tungsten Supply Chain

Blue Moon, The Elmet Group, and EQ Resources Announce a US$150-$175 Million Investment into the Springer Tungsten Complex, Nevada, to Strengthen the U.S. Tungsten Supply Chain Blue Moon, The Elmet Group, and EQ Resources Announce a US$150-$175 Million Investment into the Springer Tungsten Complex...

Blue Moon Acquires Strategic Water Rights and Land Package for Springer

Blue Moon Acquires Strategic Water Rights and Land Package for Springer Blue Moon Acquires Strategic Water Rights and Land Package for Springer PR Newswire TORONTO, Sept. 3, 2026 TORONTO, Sept. 3, 2026 /PRNewswire/ -- Blue Moon Metals Inc.("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM)is...

Blue Moon Metals Secures Water Pollution Control Permit, Approval of Construction for the Tailings Storage Facility, and Posts Reclamation Bond Allowing Start of Construction at its Springer Tungsten Project

Blue Moon Metals Secures Water Pollution Control Permit, Approval of Construction for the Tailings Storage Facility, and Posts Reclamation Bond Allowing Start of Construction at its Springer Tungsten Project Blue Moon Metals Secures Water Pollution Control Permit, Approval of Construction for the...

Blue Moon Clarifies State of Nussir Project

Blue Moon Clarifies State of Nussir Project Blue Moon Clarifies State of Nussir Project PR Newswire TORONTO, Aug. 13, 2026 TORONTO, Aug. 13, 2026 /PRNewswire/ --Blue Moon Metals Inc.("Blue Moon" or the "Company")(TSXV: MOON) (NASDAQ: BMM) today responds to and categorically refutes a series of...

This account has been verified as an official BMM representative.

Verified Account

Blue Moon Metals Inc.

Blue Moon is advancing 5 brownfield polymetallic projects, including the Nussir copper-gold-silver project in Norway, the NSG copper-zinc-gold-silver project in Norway, the Blue Moon zinc-gold-silver-copper project in the United States, the Springer tungsten-molybdenum project in the United States and the Apex germanium-gallium-copper project in the United States. All 5 projects are well located with existing local infrastructure including roads, power and historical infrastructure. Zinc, copper and tungsten are currently on the USGS and EU list of metals critical to the global economy and national security and germanium and gallium are also on the USGS list of critical metals. Major shareholders include Teck Resources Limited, funds managed by Oaktree Capital Management, Hartree Partners LP, Wheaton Precious Metals, Altius Minerals Corporation, Baker Steel Resources Trust, LNS and Monial. More information is available on the Company’s website (www.bluemoonmetals.com).

Blue Moon Metals Inc

Neutral Sentiment

<ul class="summary-bullets"><li>Elmet will receive a $450 million committed investment from the U.S. Department of War, with more than $165 million expected to support its U.S. operations and additional funding for mining and processing investments.</li><li>Elmet, Blue Moon Metals and EQ Resources announced a $150 million-$175 million investment package for the Springer Tungsten Complex.</li><li>Elmet is expected to own 70% of the Springer APT plant JV, while Blue Moon will retain ownership and operation of the Springer mine and mill.</li></ul>The Elmet Group (ELMT) shares jumped about 48% in premarket trading Monday, while Blue Moon Metals (BMM) gained more than 21%, after a series of agreements involving U.S. government funding, tungsten stockpiling and the redevelopment of Blue Moon's Springer Tungsten Complex in Nevada.Elmet announced a $450 million committed investment from the U.S. Department of War to expand tungsten mining, processing and manufacturing capacity. Separately, Elmet Technologies received a Defense Logistics Agency contract with a ceiling of up to $2 billion to supply tungsten materials for the U.S. National Defense Stockpile.Blue Moon, Elmet and EQ Resources also announced binding terms for a $150 million-$175 million investment package involving the Springer Tungsten Complex.<h2 class="st-heading-2">$450M U.S. Investment Boost</h2>The Elmet Group said the U.S. Department of War has agreed to invest $450 million in the company. The investment will be funded through an initial $200 million drawdown at closing, followed by additional drawdowns.Elmet said more than $165 million of the investment is expected to go toward operations in Maine, Michigan and Ohio, where it manufactures and processes tungsten, molybdenum and other advanced materials and components.The investment will also support Elmet's mining and processing investments in the U.S., Australia and Spain. Elmet is also establishing Elmet Refining &amp; Trading, a new division responsible for coordinating sourcing, processing and material delivery across its network.Under the transaction, the Department of War will receive redeemable preferred equity in Elmet, warrants representing up to 19.9% of ELMT's common stock on a post-transaction basis, and the right to appoint one independent director and one non-voting board observer.<h2 class="st-heading-2">$2B Defense Logistics Agency Contract</h2>Separately, Elmet Technologies received an indefinite-delivery/indefinite-quantity(IDIQ) contract from the U.S. Defense Logistics Agency.The contract has a ceiling of up to $2 billion and includes a $150 million guaranteed funded commitment.The contract covers tungsten ores, concentrates and sodium tungstate for DLA Strategic Materials and is intended to support the rebuilding of the U.S. National Defense Stockpile.The contract has a five-year base ordering period through Aug. 30, 2031, with an option for a two-year extension through Aug. 30, 2033.Elmet said it does not intend to deliver stockpile material until sufficient additional supply is available through mining investments, offtake agreements and processing-capacity expansions. Deliveries are expected to be phased as new capacity comes online.<h2 class="st-heading-2">What Is The $150M-$175M Springer Tungsten Deal?</h2>Blue Moon, Elmet and EQ Resources separately announced binding terms on Monday for a $150 million-$175 million investment package involving the Springer Tungsten Complex in Imlay, Nevada.Under the arrangement, ELMT plans to allocate approximately $150 million to the Springer transactions.&nbsp;The package also includes a $50 million tungsten prepayment facility for Blue Moon, a $25 million Elmet investment in Blue Moon, and a $75 million Elmet investment in the Springer APT plant joint venture.The additional $25 million represents a standby commitment from Elmet and EQ Resources for requirements related to placing the Springer APT plant back into production.Blue Moon's announcement says $150 million of the Department of War's $450 million investment in Elmet has been designated for these Springer transactions.The transactions remain subject to due diligence, regulatory and exchange approvals and definitive agreements.<h2 class="st-heading-2">Elmet To Own 70% Of APT Plant JV</h2>Following the planned $75 million investment, Elmet is expected to own 70% of the APT plant joint venture, with Blue Moon holding 20% and EQ Resources 10%, and Elmet operating the plant.Phase 1 is targeted at 4,000 tonnes per year of capacity, where Blue Moon will retain 100% ownership and operation of the Springer mine and mill.The mine and mill are not currently producing. Blue Moon has targeted a return to production in Q4 2027, while the APT plant is targeted to restart in the second half of 2028.Blue Moon received regulatory approvals in August that allow construction at the Springer project to proceed.<h2 class="st-heading-2">What Are Retail Investors Saying About BMM And ELMT?</h2>On Stocktwits, retail sentiment around ELMT was ‘bullish’ with ‘high’ message volume, while sentiment around BMM was ‘neutral’ amid ‘normal’ message volume.&nbsp;Over the past year, ELMT and BMM shares have surged 15.64% and 54.97%, respectively.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/viasat-space42-plan-to-build-2800-satellite-d2d-network-through-new-venture-equatys/cZtl6NVRBRl">Viasat, Space42 Plan To Build 2,800-Satellite D2D Network Through New Venture Equatys</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.  (Source: Getty Images)

Why Is ELMT Stock Surging Premarket? Three Catalysts Investors Need To Know 

The Elmet Group

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Stocktwits Polls

$BMM after this summer, the Springer story is starting to look pretty different from where it was in June. permits cleared, water secured, and now Elmet and EQ in as partners. that's a lot of ground covered fast

Eleanor Eatmon

$BMM the 33 project tungsten and antimony package gives them a pretty deep us pipeline, including several historical high grade antimony sites, not tooo shabby

Hugh Little

$BMM what stands out at Springer is the existing 1,200 tpd plant. they're not tryna restart tungsten production from a completely blank site

yno drink

$BMM tungsten is one of those materials that the U.S. has been importing almost entirely from China for years. Springer getting a construction-ready permit plus a reclamation bond posted is a concrete step toward domestic production actually happening.

$BMM noticed they went from zero construction permits to a reclamation bond posted and a $150M+ investment deal all within the same quarter. anyone else tracking how much ground Springer has covered since the summer?

$BMM Theyre going back through old drill samples and already finding some really strong tungsten results. Still a lot more left to test too which makes this pretty interesting

the goat

$BMM securing the key Nevada permits and posting the reclamation bond means Springer can now move into construction. Nice to see the tungsten project getting past the permitting stage and into actual development

Feed

News

Sentiment

Fundamentals

Info

BMM Blue Moon Metals Inc

Fundamentals

Latest BMM News